Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119649) titled 'Bortezomib combined with neoadjuvant chemotherapy for resectable thoracic esophageal squamous cell carcinoma: an exploratory clinical trial' on March 2.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Esophageal squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-16
Target Sample Size: Treatment group:13;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311671
Published by HT Digital Content Services with permission from ...